Selective IgM Deficiency in CD30+ Cutaneous Lymphoproliferative Disorder

被引:6
|
作者
Saini, Surbhi
Dettore, Andrew J.
Bhambhani, Kanta J. [2 ]
Buck, Steven
Poulik, Janet [3 ]
Savasan, Suereyya [1 ,2 ]
机构
[1] Wayne State Univ, Childrens Hosp Michigan, Pediat Blood & Marrow Transplantat Program, Div Hematol Oncol, Detroit, MI 48202 USA
[2] Wayne State Univ, Barbara Ann Karmanos Canc Ctr, Detroit, MI USA
[3] Wayne State Univ, Dept Pathol, Detroit, MI USA
关键词
lymphomatoid papulosis; primary cutaneous anaplastic large cell lymphoma; selective IgM deficiency; memory B cells; halo lesions; LARGE-CELL LYMPHOMA; MEMORY B-CELLS; FUNCTIONAL ASSESSMENT; PERIPHERAL-BLOOD; PAPULOSIS; CHILDREN; CLONES; HALO;
D O I
10.1097/MPH.0b013e31820150d5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary cutaneous anaplastic large cell lymphoma with local lymph node involvement was diagnosed in a 13-year-old boy with an ulcerative facial lesion and a history of skin lesions of lymphomatoid papulosis. The tumor regressed with chemotherapy. He continued to develop recurrent self-limited lesions of lymphomatoid papulosis, with a halo surrounding these lesions during the healing phase. He developed selective immunoglobulin M deficiency with decline in levels even 4 years after the chemotherapy with no recurrent infections noted and adequate IgG response to immunizations. Both peripheral blood IgM(+) and memory B cells were low, suggesting a possible cause-effect relationship between selective immunoglobulin M deficiency and chronic CD30(+) cutaneous lymphoproliferative disorders.
引用
收藏
页码:E156 / E159
页数:4
相关论文
共 50 条
  • [1] Two cases of cutaneous CD30+ lymphoproliferative disorder
    O'Kane, M
    Barry, J
    McMenamin, M
    Daly, P
    Barnes, L
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 : 15 - 15
  • [3] Primary cutaneous CD30+ lymphoproliferative disorders
    Wieser, Iris
    Tetzlaff, Michael T.
    Cabala, Carlos A. Torres
    Duvic, Madeleine
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (08): : 767 - 782
  • [4] A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders
    Chen, Cynthia
    Gu, Yuhan D.
    Geskin, Larisa J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (01) : 121 - +
  • [5] Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review
    Cosimo Di Raimondo
    Vishwas Parekh
    Joo Y. Song
    Steven T. Rosen
    Christiane Querfeld
    Jasmine Zain
    Xochiquetzal U. Martinez
    Farah R. Abdulla
    Current Hematologic Malignancy Reports, 2020, 15 : 333 - 342
  • [6] Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease
    Melchers, Rutger C.
    Willemze, Rein
    Vermaat, Joost S. P.
    Jansen, Patty M.
    Daniels, Laurien A.
    Putter, Hein
    Bekkenk, Marcel W.
    de Haas, Ellen R. M.
    Horvath, Barbara
    van Rossum, Michelle M.
    Sanders, Cornelus J. G.
    Veraart, Joep C. J. M.
    Vermeer, Maarten H.
    Quint, Koen D.
    BLOOD, 2020, 135 (10) : 769 - 773
  • [7] CD30+ lymphoproliferative disorders
    de Leval, Laurence
    Gaulard, Philippe
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1627 - 1630
  • [8] Characterization of Primary Cutaneous CD8+/CD30+ Lymphoproliferative Disorders
    Martires, Kathryn J.
    Ra, Seong
    Abdulla, Farah
    Cassarino, David S.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2015, 37 (11) : 822 - 833
  • [9] IL-13 Signaling in CD30+ Cutaneous Lymphoproliferative Disorders
    Wen, Yujie
    Sun, Jingru
    Yi, Shengguo
    Gao, Yumei
    Kouttab, Nick
    Morgan, John
    Wang, Yang
    Kadin, Marshall E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : 1360 - 1363
  • [10] How I treat primary cutaneous CD30+ lymphoproliferative disorders
    Shinohara, Michi M.
    Shustov, Andrei
    BLOOD, 2019, 134 (06) : 515 - 524